Surrogate Endpoints for the Treatment of Venous Leg Ulcers
- 1 December 2002
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 119 (6), 1420-1425
- https://doi.org/10.1046/j.1523-1747.2002.19629.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials: Summary of a National Institutes of Health WorkshopControlled Clinical Trials, 2001
- Surrogate endpoints: the debate goes onPharmacoepidemiology and Drug Safety, 2001
- Guidance for industry: Chronic cutaneous ulcer and burn wounds—developing products for treatmentWound Repair and Regeneration, 2001
- The accuracy of using a wound care specialty clinic database to study diabetic neuropathic foot ulcers.Wound Repair and Regeneration, 2000
- A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeksBritish Journal of Dermatology, 2000
- Statistical Validation of Surrogate Endpoints: Problems and ProposalsDrug Information Journal, 2000
- Efficacy and prognostic value of simple wound measurements.Archives of Dermatology, 1998
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- Venous leg ulcers: an analysis of underlying venous diseaseBritish Journal of Dermatology, 1993
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992